Calcium acetate
Calcium acetate
CLINICAL USE
Phosphate binding agent
DOSE IN NORMAL RENAL FUNCTION
1–4 tablets, 3 times daily
PHARMACOKINETICS
Molecular weight                           :158.2 %Protein binding                           :– %Excreted unchanged in urine     : – Volume of distribution (L/kg)       :–half-life – normal/ESRD (hrs)      :– DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function. Titrate to response 10 to 20     : Dose as in normal renal function. Titrate to response <10           : Dose as in normal renal function. Titrate to response DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unknown dialysability. Dose as in normal renal function HD                     :Unknown dialysability. Dose as in normal renal functionHDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsCan impair absorption of some drugs, e.g. iron, ciprofloxacin ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
– Comments
Take tablets with meals OTHER INFORMATION
Calcium acetate (anhydrous): calcium content per gram = 250 mg (6.2 mmol).
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home